For: | Janczewska E, Kołek MF, Lorenc B, Klapaczyński J, Tudrujek-Zdunek M, Sitko M, Mazur W, Zarębska-Michaluk D, Buczyńska I, Dybowska D, Czauż-Andrzejuk A, Berak H, Krygier R, Jaroszewicz J, Citko J, Piekarska A, Dobracka B, Socha Ł, Deroń Z, Laurans Ł, Białkowska-Warzecha J, Tronina O, Adamek B, Tomasiewicz K, Simon K, Pawłowska M, Halota W, Flisiak R. Factors influencing the failure of interferon-free therapy for chronic hepatitis C: Data from the Polish EpiTer-2 cohort study. World J Gastroenterol 2021; 27(18): 2177-2192 [PMID: 34025072 DOI: 10.3748/wjg.v27.i18.2177] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i18/2177.htm |
Number | Citing Articles |
1 |
Busayo I. Ajuwon, Oluwatosin N. Awotundun, Alice Richardson, Katrina Roper, Meru Sheel, Nurudeen Rahman, Abideen Salako, Brett A. Lidbury. Machine learning prediction models for clinical management of blood-borne viral infections: a systematic review of current applications and future impact. International Journal of Medical Informatics 2023; 179: 105244 doi: 10.1016/j.ijmedinf.2023.105244
|
2 |
Paweł Pabjan, Michał Brzdęk, Magdalena Chrapek, Kacper Dziedzic, Krystyna Dobrowolska, Katarzyna Paluch, Anna Garbat, Piotr Błoniarczyk, Katarzyna Reczko, Piotr Stępień, Dorota Zarębska-Michaluk. Are There Still Difficult-to-Treat Patients with Chronic Hepatitis C in the Era of Direct-Acting Antivirals?. Viruses 2022; 14(1): 96 doi: 10.3390/v14010096
|
3 |
Michał Brzdęk, Dorota Zarębska-Michaluk, Federica Invernizzi, Marta Cilla, Krystyna Dobrowolska, Robert Flisiak. Decade of optimizing therapy with direct-acting antiviral drugs and the changing profile of patients with chronic hepatitis C. World Journal of Gastroenterology 2023; 29(6): 949-966 doi: 10.3748/wjg.v29.i6.949
|
4 |
Ahmed N. Farrag, Ahmed M. Kamel, Iman A. El‐Baraky. Opportunities and challenges for the application of artificial intelligence paradigms into the management of endemic viral infections: The example of Chronic Hepatitis C Virus. Reviews in Medical Virology 2024; 34(2) doi: 10.1002/rmv.2514
|
5 |
Michał Brzdęk, Dorota Zarębska-Michaluk, Piotr Rzymski, Beata Lorenc, Adam Kazek, Magdalena Tudrujek-Zdunek, Justyna Janocha-Litwin, Włodzimierz Mazur, Dorota Dybowska, Hanna Berak, Anna Parfieniuk-Kowerda, Jakub Klapaczyński, Marek Sitko, Barbara Sobala-Szczygieł, Anna Piekarska, Robert Flisiak. Changes in characteristics of patients with hepatitis C virus-related cirrhosis from the beginning of the interferon-free era. World Journal of Gastroenterology 2023; 29(13): 2015-2033 doi: 10.3748/wjg.v29.i13.2015
|
6 |
Michał Brzdęk, Dorota Zarębska-Michaluk, Michał Kukla, Justyna Janocha-Litwin, Dorota Dybowska, Ewa Janczewska, Beata Lorenc, Hanna Berak, Włodzimierz Mazur, Magdalena Tudrujek-Zdunek, Jakub Klapaczyński, Anna Piekarska, Marek Sitko, Łukasz Laurans, Anna Parfieniuk-Kowerda, Robert Flisiak. Real-world experience with direct-acting antiviral therapy in HCV-infected patients with cirrhosis and esophageal varices. Pharmacological Reports 2024; 76(5): 1114 doi: 10.1007/s43440-024-00639-9
|
7 |
Michał BRZDĘK, Dorota ZARĘBSKA-MICHALUK, Krzysztof TOMASIEWICZ, Magdalena TUDRUJEK-ZDUNEK, Beata LORENC, Włodzimierz MAZUR, Hanna BERAK, Justyna JANOCHA-LITWIN, Jakub KLAPACZYŃSKI, Marek SITKO, Ewa JANCZEWSKA, Dorota DYBOWSKA, Anna PARFIENIUK-KOWERDA, Anna PIEKARSKA, Jerzy JAROSZEWICZ, Robert FLISIAK. Effectiveness and safety of direct-acting antivirals in the therapy of HCV-infected elderly people. Minerva Medica 2024; 115(3) doi: 10.23736/S0026-4806.24.09238-3
|